Advances in Small-Molecule Synthesis - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Advances in Small-Molecule Synthesis
Approaches in cyclization, palladium-catalyzed cross couplings, fluorination, and natural product synthesis help to optimize routes for select drugs.

Pharmaceutical Technology
Volume 34, Issue 12, pp. 40-42


1. G. Rassias et al., Org. Proc. Res. Dev. 14 (1), 92–98 (2010).

2. B. Halford, Chem. Eng. News 88 (41), 7 (2010).

3. M. Jacoby, Chem. Eng. News 88 (7), 60 (2010).

4. N.T.S. Phan, M. Van Der Sluys, and C.W. Jones, Adv. Synth. Catal. 348 (6), 609–679 (2006).

5. C.W. Jones et al., Organometallics 24 (18), 4351–4361 (2005).

6. C.W. Jones et al., Adv. Synth. Catal 347 (1), 161–171 (2005).

7. M. Beller et al., Angew. Chem. Int. Ed. 49 (47), 8988–8992 (2010).

8. K. Stradiotto et al., Angew. Chem. Int. Ed., 49 (24) 4071–4074 (2010).

9. M. Stradiotto et al., Angew. Chem. Int. Ed. 49 (46) 8686–8690 (2010).

10. D. Fischer and R. Sarpong, J. Amer. Chem. Soc. 132 (17), 5926–5927 (2010).

11. C. Drahl, Chem. Eng. News 88 (17), 11 (2010).

12. T. Pingping, T Furuya, and T. Ritter J. Am. Chem. Soc. 132 (34), 12150–12154 (2010).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: Pharmaceutical Technology,
Click here